Enzymotec wins Israeli phytosterol patent

- Last updated on GMT

Related tags: Denmark, European union, New zealand

Israeli-based lipid specialist, Enzymotec, has been granted a home turf patent for the composition and production of its phytosterol ingredient, Cardiobeat.

The patent follows previous approvals granted in China and New Zealand as well as new dietary ingredient status in the US and novel food approval in the European Union.

Further process and efficacy patents are pending in other international jurisdictions.

CardiaBeat, derived from an omega-3 glyceride matrix, has been shown to reduce the likelihood of cardiovascular disease in clinical trials.

Related news

Show more

Related products

show more

Related suppliers

Follow us


View more